SCHEMBL1637430

SCHEMBL1637430

CCCN(CCC)CCCCN(C)Cc1ccc(CN(Cc2nccn2C)Cc2nccn2CC(=O)OCC)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 2/20 0.63
FPR2 P25090 2/20 0.39
TSHR P16473 4/20 0.37
NPSR1 Q6W5P4 2/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
USP2 O75604 2/20 0.36
ALDH1A1 P00352 2/20 0.36
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C19 P33261 1/20 0.36
LTA4H P09960 3/20 0.34
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1636570 0.95 CXCR4 (0.55) CXCR4FPR2TSHRNPSR1LMNA
SCHEMBL1637878 0.89 CXCR4 (0.67) CXCR4MEN1KMT2ABCHEACHE
SCHEMBL1638006 0.86 CXCR4 (0.60) CXCR4TSHRNPSR1LMNATP53
SCHEMBL1637089 0.84 CXCR4 (0.60) CXCR4FPR2MEN1KMT2ABCHE
SCHEMBL1638752 0.84 CXCR4 (0.55) CXCR4FPR2NPSR1LMNAMEN1
SCHEMBL1637893 0.81 CXCR4 (0.61) CXCR4FPR2MEN1KMT2APOLB
SCHEMBL1637433 0.80 CXCR4 (0.49) CXCR4FPR2TSHRMEN1KMT2A
SCHEMBL2189962 0.80 CXCR4 (0.73) CXCR4TSHRNPSR1LMNATP53
SCHEMBL1637333 0.79 CXCR4 (0.61) CXCR4NPSR1LMNAMEN1KMT2A
SCHEMBL1636573 0.79 CXCR4 (0.48) CXCR4FPR2MEN1KMT2ALTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1724263-B1 BASIC AMINE COMPOUND AND USE THEREOF KUREHA CORP (JP) 2014-03-05 EP disclosed
US-20110172212-A1 AMINE-BASED COMPOUND AND USE THEREOF KUREHA CORPORATION (JP) 2011-07-14 US disclosed
US-7932281-B2 Amine-based compound and use thereof KUREHA CORPORATION (JP) 2011-04-26 US disclosed
US-20070208007-A1 Amine-Based Compound and Use Thereof KUREHA CORPORATION (JP) 2007-09-06 US disclosed
EP-1724263-A1 BASIC AMINE COMPOUND AND USE THEREOF Kureha Corporation (JP) 2006-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172212-A1 AMINE-BASED COMPOUND AND USE THEREOF NR0B2, NR5A2, NR1D2 CXCR4 86/4885FPR2 152/4885TSHR 1111/4885
US-20070208007-A1 Amine-Based Compound and Use Thereof NR0B2, NR5A2, NR2E1 CXCR4 100/4885FPR2 137/4885TSHR 1353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.